New Roche Award for Antibody-based Cancer Therapy Research
News May 15, 2013
In a newly created award, pRED`s Discovery Oncology unit of Roche in Penzberg, Germany invites European researchers to submit abstracts which describe their scientific work in the field of tumor-selective membrane targets for antibody-based cancer therapy. The award aims to honor and support outstanding research in the academia field and will further strengthen Roche´s interaction with the international research community.
“Roche has a long tradition of successful exchange with many research institutions all over the world,” states Klaus Bosslet, Head of Discovery Oncology Penzberg. “With the new award we emphasize our commitment to intensifying collaboration with academia and continuing support of innovative cancer research.”
The abstracts will be reviewed by a jury consisting of scientific experts from academia and Roche. Qualified applicants include graduate students and postdoctoral fellows from the research labs based in Europe. The authors of the ten best contributions will be invited to the Roche Penzberg campus near Munich, for oral presentation, poster discussion and award ceremony in November 2013. The three winners will be selected at the symposium and receive an award of 4,000 €, 2,000 €, and 1,000 €, respectively.
For submission and related information, please visit www.roche.de/abstract. The deadline for abstract submission is August 15, 2013.
H7N9 Influenza Vaccine Clinical Trials CommenceNews
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States. The Phase 2 studies will test different dosages of the inactivated influenza vaccine candidate as well as different vaccination schedules. The studies also will evaluate whether an adjuvant boosts the immune responses of people receiving the vaccine.
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
Alternative to Antibiotics: Antibody Approach for Treating Multidrug-Resistant Bacterial InfectionsNews
Researchers are developing a promising alternative to antibiotic treatment for infections caused by Klebsiella pneumoniae bacteria resistant to carbapenem antibiotics. The approach uses antibodies to target the K. pneumoniae protective capsule polysaccharide.READ MORE
Comments | 0 ADD COMMENT
7th International Conference on Bacteriology and Infectious Diseases
Jun 04 - Jun 05, 2018